| Literature DB >> 32571766 |
S Pérez Codesido1, A Rosado Ingelmo1, E Gómez de la Fuente1, E García García1, M Privitera Torres1, M A Tejedor Alonso1.
Abstract
Entities:
Keywords: Hypocomplementemic; Omalizumab; Treatment; Urticarial vasculitis
Mesh：
Substances：
Year: 2020 PMID： 32571766 DOI： 10.18176/jiaci.0486
Source DB: PubMed Journal: J Investig Allergol Clin Immunol ISSN： 1018-9068 Impact factor: 4.333